Devulapalli S, Pinto N, Gandothra C, Jayam-Trouth A, Kurukumbi M
Department of Neurology, Howard University Hospital, Washington, D.C., USA.
Case Rep Neurol. 2012 Jan;4(1):84-91. doi: 10.1159/000338811. Epub 2012 Apr 26.
Hypercoagulability occurs in 15% of patients with malignancy and represents a clinical spectrum ranging from abnormal coagulation tests but no clinically evident thromboembolic disease, to arterial and venous thrombosis, migratory thrombophlebitis, nonbacterial thrombotic endocarditis (NBTE) and disseminated intravascular coagulation. The combination of increased procoagulant activity and decreased fibrinolytic activity accelerates the prothrombotic potential of endothelial cells in malignancy. NBTE is a rare manifestation of cancer-induced hypercoagulability and is commonly seen with mucin-producing adenocarcinomas, but rarely seen with ovarian clear cell carcinoma (OCCC). Cerebrovascular embolization ranges from 14-91% in NBTE. We report a rare case of a 62-year-old female presenting with occipital stroke as a consequence of NBTE in OCCC. Association of NBTE in OCCC has only been reported in 2 cases so far, but presentation with stroke has never been reported in the literature.
高凝状态在15%的恶性肿瘤患者中出现,代表了一个临床谱,范围从凝血试验异常但无临床明显血栓栓塞性疾病,到动脉和静脉血栓形成、游走性血栓性静脉炎、非细菌性血栓性心内膜炎(NBTE)和弥散性血管内凝血。促凝活性增加和纤溶活性降低的联合作用加速了恶性肿瘤中内皮细胞的促血栓形成潜能。NBTE是癌症诱导的高凝状态的一种罕见表现,常见于产生黏液的腺癌,但很少见于卵巢透明细胞癌(OCCC)。在NBTE中,脑血管栓塞的发生率为14% - 91%。我们报告了一例罕见病例,一名62岁女性因OCCC中的NBTE导致枕叶卒中。迄今为止,OCCC中NBTE的关联仅在2例中被报道,但文献中从未报道过以卒中为表现的情况。